본문 바로가기

2022년 이전/Corporate Disclosure

2020-06-30 Korean stock market company disclosure

[KOSPI]

 

# CS Wind

http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20200630800131

- Wind tower contract with Siemens Gamesa.

- Produce in Taiwan factory

- Amount: 20.8 billion KRW

 

# Hyundai Livart

http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20200630800431

- Delay on facility extension

- Prior: 2020-06-30 >> 2021-03-31

 

# Celltrion

http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20200630800458

- Sales contract: Biosimilar antibody drug (RemsimaSC, Herjuma, Truxima etc.)

- Amount: 170.8 billion KRW

 

 

[KOSDAQ]

 

# Exicon

http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20200630900102

- Sales contract: SSD Tester to Samsung China

- Amount: 2.15 billion KRW

 

# SCI Information Service

http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20200630900160

- Inquiry Disclosure: market rumor ("The largest shareholder will sell his shares to possible SI(such as NHN, Toss, and Naver")

- Answer: Not decided

[KOSPI]

 

# CS Wind

http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20200630800131

- Wind tower contract with Siemens Gamesa.

- Produce in Taiwan factory

- Amount: 20.8 billion KRW

 

# Hyundai Livart

http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20200630800431

- Delay on facility extension

- Prior: 2020-06-30 >> 2021-03-31

 

# Celltrion

http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20200630800458

- Sales contract: Biosimilar antibody drug (RemsimaSC, Herjuma, Truxima etc.)

- Amount: 170.8 billion KRW

 

 

[KOSDAQ]

 

# Exicon

http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20200630900102

- Sales contract: SSD Tester to Samsung China

- Amount: 2.15 billion KRW

 

# SCI Information Service

http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20200630900160

- Inquiry Disclosure: market rumor ("The largest shareholder will sell his shares to possible SI(such as NHN, Toss, and Naver")

- Answer: Not decided. Will announce within 1 month.